Validity and Reliability of SCIM-SR

To determine the validity and reliability of SCIM-SR, patients will fill out SCIM 3 and SR.

Completed

Looking for future studies?

Key information

Conditions

Spinal Cord Injuries Central Nervous System Diseases Nervous System Diseases Spinal Cord Diseases Trauma, Nervous System Wounds and Injuries

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Cansın Medin Ceylan

Istanbul, None Selected, 34147, Turkey (Türkiye)

About this study

To determine the validity and reliability of SCIM-SR, patients will fill out SCIM 3 and SR. scım-sr Turkish form has been created. Patients with spinal cord injuries who applied to our physical therapy clinic filled out the form twice.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

SCI >1 month
18-70 years
agree to participate
give written consent

Exclusion criteria

not read Turkish,
not write Turkish,
cognitive problems

Treatment and study plan

SCIM-SR

Other

SCIM-SR was a self-reported scale that evaluated the independence of patients.

Primary outcomes

SCIM-SR

Time frame: baseline

scım-sr was a self-reported scale that evaluated the independence of patients.

Sponsors and collaborators

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Other Gov

Registry information

Official study title

Validity and Reliability of the Turkish Version of the Spinal Cord Independence Measure Self-Report

Important dates

Study start: 2023
Primary completion: 2024
Study completion: 2024
First posted: Oct 24, 2024
Registry last updated: Oct 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed